Our results showed redox imbalance and decreased vitality of SOD and GSH occurred in CCl4-treated groups, which is consistent with similar liver fibrosis model (Zhang et al., 2018; Liu et al., 2021), while VSC-CDs could eliminate oxygen-free radicals to reduce oxidative stress damage. The gene discussed is SOD1; the disease is Hepatic fibrosis.